Integration of traditional Chinese medicine with western medicine had some benefits for patients with SARS
Citation: Chen Y, Guo JJ, Healy DP, Zhan S. Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: A meta-analysis. Pharmacy Practice 2007;5(1):1-9
What is this? Like COVID-19, severe acute respiratory syndrome (SARS) is an acute respiratory disease caused by a coronavirus. Therapy which integrated traditional Chinese medicine (TCM) with western medicine (WM) was used to treat patients with these earlier coronaviruses and might be considered as a treatment for COVID-19.
In this systematic review, the authors searched for randomized and non-randomized trials that compared the treatment effects of integrative TCM/WM with WM alone in the treatment of severe acute respiratory syndrome (SARS). They restricted their search to articles published in English or Chinese between 2002 and 2006. They did their search in August 2006. They identified 16 randomized trials (866 participants) and 8 non-randomized controlled trials (812 participants).
What works: The integration of traditional Chinese medicine with western medicine significantly improved some patient outcomes compared to western medicine alone, including resolution of lung infiltrate, CD4+, average daily use of corticosteroids and time to abatement of fever. There were no significant differences for mortality rate or cure rate.
What doesn’t work: Nothing noted.
What’s uncertain: Nothing noted.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.